A Study to Investigate the Excretion Balance of SB-681323 in Healthy Male Volunteers [Type 3C]

Trial Profile

A Study to Investigate the Excretion Balance of SB-681323 in Healthy Male Volunteers [Type 3C]

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Dilmapimod (Primary)
  • Indications Atherosclerosis; Chronic obstructive pulmonary disease; Neuropathic pain; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top